Next, we sought to verify the ability of the CD133 aptamers to deliver DOX into bulk liver cancer cells and liver cancer sphere-forming cells, which are in vitro surrogates of liver cancer stem cells [25], using alternative experimental approaches. This evidence concerns the gene PROM1 and liver cancer.